JP7475718B2 - Oral Care Compositions - Google Patents
Oral Care Compositions Download PDFInfo
- Publication number
- JP7475718B2 JP7475718B2 JP2022110040A JP2022110040A JP7475718B2 JP 7475718 B2 JP7475718 B2 JP 7475718B2 JP 2022110040 A JP2022110040 A JP 2022110040A JP 2022110040 A JP2022110040 A JP 2022110040A JP 7475718 B2 JP7475718 B2 JP 7475718B2
- Authority
- JP
- Japan
- Prior art keywords
- present
- pine bark
- bark extract
- oral composition
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 50
- 229940106587 pine bark extract Drugs 0.000 claims description 40
- 235000020741 pine bark extract Nutrition 0.000 claims description 40
- 240000007313 Tilia cordata Species 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 description 29
- 241000196324 Embryophyta Species 0.000 description 28
- 208000028169 periodontal disease Diseases 0.000 description 25
- 240000005979 Hordeum vulgare Species 0.000 description 21
- 235000007340 Hordeum vulgare Nutrition 0.000 description 21
- 239000000843 powder Substances 0.000 description 19
- 240000007154 Coffea arabica Species 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 241000605862 Porphyromonas gingivalis Species 0.000 description 17
- 244000017020 Ipomoea batatas Species 0.000 description 15
- 235000002678 Ipomoea batatas Nutrition 0.000 description 15
- 244000046146 Pueraria lobata Species 0.000 description 15
- 235000010575 Pueraria lobata Nutrition 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 230000009422 growth inhibiting effect Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 235000007460 Coffea arabica Nutrition 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- 238000009833 condensation Methods 0.000 description 7
- 230000005494 condensation Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 241000533293 Sesbania emerus Species 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 241001236215 Pinus parviflora Species 0.000 description 3
- 241001236212 Pinus pinaster Species 0.000 description 3
- 235000005105 Pinus pinaster Nutrition 0.000 description 3
- 229920001991 Proanthocyanidin Polymers 0.000 description 3
- 241000731396 Pueraria montana var. thomsonii Species 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000007910 chewable tablet Substances 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- -1 round Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000007320 Pinus strobus Species 0.000 description 2
- 235000008578 Pinus strobus Nutrition 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241000907897 Tilia Species 0.000 description 2
- 235000015450 Tilia cordata Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000001430 tilia cordata extract Substances 0.000 description 2
- 239000003021 water soluble solvent Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- XIMADJWJJOMVID-UHFFFAOYSA-N 2-phenyl-3,4-dihydro-2h-chromene-3,4-diol Chemical compound OC1C(O)C2=CC=CC=C2OC1C1=CC=CC=C1 XIMADJWJJOMVID-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- IBFXLTFIVWRUQC-OVGYCKTGSA-N 9b,10b-epoxyroridin d Chemical compound C([C@@]12[C@]3(C)[C@H]4C[C@H]1OC1C5OC5(C)CCC13COC(=O)C1O[C@@]1(C)CCOC(\C=C\C=C/C(=O)O4)C(O)C)O2 IBFXLTFIVWRUQC-OVGYCKTGSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000005638 Austrian pine Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000769888 Canephora <angiosperm> Species 0.000 description 1
- 241000723377 Coffea Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000018783 Dacrycarpus dacrydioides Nutrition 0.000 description 1
- 240000006055 Dacrydium cupressinum Species 0.000 description 1
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 125000002435 L-phenylalanyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 235000008565 Pinus banksiana Nutrition 0.000 description 1
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 241001236210 Pinus pumila Species 0.000 description 1
- 235000013697 Pinus resinosa Nutrition 0.000 description 1
- 235000008585 Pinus thunbergii Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000002168 Tilia europaea Nutrition 0.000 description 1
- 235000021525 Tilia platyphyllos Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 229940032081 pine bark extract 30 mg Drugs 0.000 description 1
- 229940031234 pine bark extract 50 mg Drugs 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940092665 tea leaf extract Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
- Confectionery (AREA)
Description
本発明は、歯周病の予防・改善効果を有する経口組成物に関する。 The present invention relates to an oral composition that has the effect of preventing and improving periodontal disease.
歯周病は、細菌の感染によって引き起こされる炎症性疾患であり、歯垢(プラーク)の中の細菌によって歯肉に炎症が引き起こされ、そのまま放置すると歯を失うおそれのある病気である。また、この歯周病が進行すると、歯周病菌が口腔内の毛細血管を通して全身の臓器に運ばれ、糖尿病、肺炎、動脈硬化、心筋梗塞等の全身疾患を引き起こす可能性があるともいわれている。 Periodontal disease is an inflammatory disease caused by bacterial infection. Bacteria in dental plaque cause inflammation of the gums, and if left untreated, it can lead to tooth loss. It is also said that as periodontal disease progresses, periodontal bacteria can be carried to organs throughout the body through capillaries in the oral cavity, potentially causing systemic diseases such as diabetes, pneumonia, arteriosclerosis, and myocardial infarction.
このような歯周病の予防・改善する経口組成物としては、例えば、松樹皮抽出物を含有する組成物が有効であることが報告されている(特許文献1及び2参照)。 As an oral composition for preventing and improving such periodontal disease, for example, a composition containing pine bark extract has been reported to be effective (see Patent Documents 1 and 2).
この松樹皮抽出物は歯周病の予防・改善効果を有するものの、更なる効果の向上が求められている。 Although this pine bark extract has the effect of preventing and improving periodontal disease, further improvements in its effectiveness are required.
本発明はかかる事情に鑑みてなされたものであり、本発明の課題は、歯周病に対する優れた予防及び/又は改善効果を奏する経口組成物を提供することにある。 The present invention has been made in consideration of these circumstances, and the objective of the present invention is to provide an oral composition that has excellent preventive and/or ameliorative effects against periodontal disease.
本発明者らは、オーラルケアの研究に取り組み、特に歯周病をより効果的に予防及び/又は改善する食品及び医薬品について鋭意検討した結果、特定の植物素材が松樹皮抽出物の歯周病の予防・改善効果を増強することを見出し、本発明を完成するに至った。 The inventors have been engaged in research into oral care, and as a result of intensive investigations into foods and medicines that can more effectively prevent and/or improve periodontal disease, they have discovered that certain plant materials enhance the effects of pine bark extract in preventing and improving periodontal disease, which led to the completion of the present invention.
すなわち、本発明は、以下の通りのものである。
[1]松樹皮抽出物と、コーヒーノキ、菩提樹、葛花、大麦若葉及び甘藷若葉から選ばれる少なくとも1つの植物素材とを含有することを特徴とするオーラルケア用経口組成物。
[2]松樹皮抽出物を有効成分とするオーラルケア用経口組成物において、さらに、コーヒーノキ、菩提樹、葛花、大麦若葉及び甘藷若葉から選ばれる少なくとも1つの植物素材を含有することを特徴とするオーラルケア用経口組成物。
[3]松樹皮抽出物と、コーヒーノキ及び菩提樹から選ばれる少なくとも1つの植物素材とを含有することを特徴とする経口組成物。
That is, the present invention is as follows.
[1] An oral composition for oral care, comprising a pine bark extract and at least one plant material selected from the group consisting of coffee tree, linden tree, kudzu flower, young barley leaves, and young sweet potato leaves.
[2] An oral composition for oral care comprising a pine bark extract as an active ingredient, further comprising at least one plant material selected from the group consisting of coffee tree, linden tree, kudzu flower, young barley leaves, and young sweet potato leaves.
[3] An oral composition comprising a pine bark extract and at least one plant material selected from the group consisting of coffee trees and linden trees.
本発明の経口組成物は、歯周病に対する優れた予防及び/又は改善効果を有する。 The oral composition of the present invention has excellent preventive and/or ameliorative effects against periodontal disease.
本発明の経口組成物は、松樹皮抽出物と、コーヒーノキ、菩提樹、葛花、大麦若葉及び甘藷若葉から選ばれる少なくとも1つの植物素材(副素材ということがある)とを含有することを特徴とする。副素材は、1種単独(例えばコーヒーノキのみ)で用いてもよいし、2種以上組み合わせて用いてもよい。副素材を2種以上組み合わせて用いる場合、松樹皮抽出物の効果を増強する効果の高い副素材同士を組み合わせることが好ましい。 The oral composition of the present invention is characterized by containing a pine bark extract and at least one plant material (sometimes referred to as a secondary material) selected from coffee tree, linden tree, kudzu flower, young barley leaves, and young sweet potato leaves. The secondary material may be used alone (for example, only coffee tree) or in combination of two or more types. When using a combination of two or more types of secondary materials, it is preferable to combine secondary materials that are highly effective in enhancing the effect of the pine bark extract.
松樹皮抽出物と植物素材の組合せが、歯周病の原因菌であるPorphyromonas gingivalisの増殖を効果的に抑制することから、本発明の経口組成物は、歯周病を有効に予防及び/又は改善することができる。また、本発明の経口組成物は、Porphyromonas gingivalisがタンパク質やアミノ酸を代謝した際に生じる悪臭を抑制し、歯周病に特有な口臭を予防及び/又は改善することができる。 The combination of pine bark extract and plant material effectively inhibits the proliferation of Porphyromonas gingivalis, a bacterium that causes periodontal disease, and therefore the oral composition of the present invention can effectively prevent and/or ameliorate periodontal disease. In addition, the oral composition of the present invention can inhibit the bad odor that is generated when Porphyromonas gingivalis metabolizes proteins and amino acids, and can prevent and/or ameliorate the bad breath that is characteristic of periodontal disease.
[松樹皮抽出物]
本発明の経口組成物における松樹皮抽出物は、主な成分の一つとして、プロアントシアニジンを含有する。プロアントシアニジンは、フラバン-3-オールおよび/又はフラバン-3,4-ジオールを構成単位とする重合度が2以上の縮重合体からなる化合物群である。
[Pine bark extract]
The pine bark extract in the oral composition of the present invention contains proanthocyanidin as one of its main components. Proanthocyanidin is a group of compounds consisting of condensation polymers having a degree of polymerization of 2 or more, whose constituent units are flavan-3-ol and/or flavan-3,4-diol.
松樹皮抽出物の原料としては、フランス海岸松(Pinus Martima)、カラマツ、クロマツ、アカマツ、ヒメコマツ、ゴヨウマツ、チョウセンマツ、ハイマツ、リュウキュウマツ、ウツクシマツ、ダイオウマツ、シロマツ等を挙げることができ、これらの中でも、フランス海岸松が好ましい。得られた抽出物は、必要に応じて濃縮又は乾燥して、液状、ペースト状、又は粉末としてもよい。また、松樹皮抽出物は、市販品を用いることができ、例えば、株式会社東洋新薬製の松樹皮抽出物(フラバンジェノール(登録商標))を用いることができる。 The raw material for the pine bark extract may be French maritime pine (Pinus Martima), larch, black pine, red pine, Japanese white pine, Japanese white pine, Korean pine, Japanese stone pine, Ryukyu pine, Japanese white pine, giant pine, white pine, etc., of which French maritime pine is preferred. The obtained extract may be concentrated or dried as necessary to form a liquid, paste, or powder. In addition, commercially available pine bark extracts may be used, for example, pine bark extract (Flavangenol (registered trademark)) manufactured by Toyo Shinyaku Co., Ltd.
また、本発明の経口組成物における松樹皮抽出物は、プロアントシアニジンとして重合度が2以上の縮重合体が含有されていることが好ましい。特に、重合度が低い縮重合体が多く含まれるプロアントシアニジンが好ましい。重合度の低い縮重合体としては、例えば、重合度が2~30の縮重合体(2~30量体)であり、重合度が2~10の縮重合体(2~10量体)が好ましく、重合度が2~4の縮重合体(2~4量体)がさらに好ましい。本明細書では、重合度が2~4の重合体を、OPC(oligomeric proanthocyanidin)という。本発明の経口組成物における松樹皮抽出物は、OPCを20質量%以上含有することが好ましく、30質量%以上含有することがより好ましく、40質量%以上含有することがさらに好ましい。 The pine bark extract in the oral composition of the present invention preferably contains a condensation polymer having a degree of polymerization of 2 or more as a proanthocyanidin. In particular, proanthocyanidins containing a large amount of condensation polymers having a low degree of polymerization are preferred. Examples of condensation polymers having a low degree of polymerization include condensation polymers having a degree of polymerization of 2 to 30 (dimers to 30-mers), preferably condensation polymers having a degree of polymerization of 2 to 10 (dimers to 10-mers), and more preferably condensation polymers having a degree of polymerization of 2 to 4 (dimers to tetramers). In this specification, polymers having a degree of polymerization of 2 to 4 are referred to as OPCs (oligomeric proanthocyanidins). The pine bark extract in the oral composition of the present invention preferably contains 20% by mass or more of OPCs, more preferably 30% by mass or more, and even more preferably 40% by mass or more.
松樹皮抽出物は、松の樹皮を水又は有機溶媒で抽出して得られる。水を用いる場合には温水・熱水が好ましく用いられる。抽出に用いる有機溶媒としては、メタノール、エタノール、1-プロパノール、2-プロパノール、1-ブタノール、2-ブタノール、ブタン、アセトン、ヘキサン、シクロヘキサン、プロピレングリコール、含水エタノール、含水プロピレングリコール等の食品あるいは薬剤の製造に許容される有機溶媒が好ましく用いられる。これらの水、有機溶媒は単独で用いてもよいし、2種以上の溶媒を組み合わせて用いてもよい。特に、水、エタノール、含水エタノール等の水溶性溶媒が好ましく用いられる。 Pine bark extract is obtained by extracting pine bark with water or an organic solvent. When water is used, warm water or hot water is preferably used. As the organic solvent used for extraction, organic solvents acceptable for the production of food or medicine, such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, butane, acetone, hexane, cyclohexane, propylene glycol, aqueous ethanol, aqueous propylene glycol, etc., are preferably used. These water and organic solvents may be used alone or in combination of two or more solvents. In particular, water-soluble solvents such as water, ethanol, aqueous ethanol, etc. are preferably used.
[植物素材(副素材)]
本発明における植物素材(副素材)は、植物素材そのものの他、その粉砕物、搾汁、抽出物等の加工処理物を用いることができる。粉砕物としては、粉末、顆粒等が挙げられる。絞汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末として用いることもできる。抽出物は、適当な溶媒を用いて抽出することにより得ることができ、溶媒としては、例えば、水、エタノール、含水エタノール等の水溶性溶媒を用いることができる。
以下、各植物素材について説明する。
[Plant materials (secondary materials)]
In the present invention, the plant material (secondary material) may be the plant material itself, or a processed product such as crushed product, juice, or extract. Examples of crushed products include powder and granules. The juice or extract may be in liquid form, but can also be used as a paste or dry powder. The extract can be obtained by extraction using a suitable solvent, and examples of the solvent that can be used include water-soluble solvents such as water, ethanol, and aqueous ethanol.
Each plant material will be described below.
(コーヒーノキ)
本発明で使用する「コーヒーノキ」とは、アカネ科(Rubiaceae)、コーヒーノキ属(Coffea)の植物であり、例えば、アラビアコーヒーノキ(Coffee arabica)、ロブスタコーヒーノキ(Coffee canephora Pierr.)、Coffee robusta、リベリアコーヒーノキ(Coffee liberica)等を用いることができる。本発明の植物素材として用いる部位としては、種子(コーヒー豆)が好ましく、焙煎したものを用いてもよいが、焙煎していない生の種子を用いることがより好ましい。
(Coffee tree)
The "coffee tree" used in the present invention refers to a plant of the Rubiaceae family and the Coffea genus, and examples that can be used include Coffee arabica, Coffee canephora Pierr., Coffee robusta, and Coffee liberica. The part of the plant used as the plant material of the present invention is preferably the seeds (coffee beans), and although roasted seeds may be used, it is more preferable to use raw, unroasted seeds.
(菩提樹)
菩提樹は、シナノキ科(Tiliaceae)の植物であり、本発明に用いられる菩提樹としては、ナツボダイジュ(Tilia platyphyllos Scop.)、フユボダイジュ(Tilia cordata Mill.)、セイヨウシナノキ(Tilia europaea L.)などのシナノキ科、シナノキ属(Tilia)の植物が挙げられる。本発明の植物素材として用いる部位としては、花が好ましい。
(linden)
Linden trees are plants of the Tiliaceae family, and examples of linden trees that can be used in the present invention include plants of the Tilia genus and Tilia family, such as Tilia platyphyllos Scop., Tilia cordata Mill., and Tilia europaea L. The part of the plant that can be used as the plant material in the present invention is preferably the flower.
(葛花)
葛花としては、マメ科クズ属に属する植物の花が用いられる。葛は、マメ科クズ属のつる性の多年草植物である。葛花としては、蕾から全開した花までのいずれの過程で採取したものを用いてもよく、各過程で採取したものを混合して用いることもできる。葛の種類としては、特に制限はないが、プエラリア・トムソニイ(Pueraria thomsonii)、プエラリア・ロバータ(Pueraria lobata)、プエラリア・スンバーギアナ(Pueraria thunbergiana)等を例示することができ、プエラリア・トムソニイ(Pueraria thomsonii)が好ましい。
(Kudzu flower)
As the kudzu flower, the flower of a plant belonging to the genus Pueraria of the family Fabaceae is used. Kudzu is a creeping perennial plant belonging to the genus Pueraria of the family Fabaceae. As the kudzu flower, the one collected at any stage from bud to fully opened flower can be used, and the ones collected at each stage can be mixed and used. The type of kudzu is not particularly limited, but can be exemplified by Pueraria thomsonii, Pueraria lobata, Pueraria thunbergiana, etc., and Pueraria thomsonii is preferred.
(大麦若葉)
大麦(Hordeum vulgare L.)は、中央アジア原産とされ、イネ科に属する一年生又は越年生草本であり、穂形により、二条大麦や六条大麦などに大別される。本発明の植物素材として用いる大麦若葉は、通常入手可能なものであれば特に限定されず、二条大麦や六条大麦などのいずれの大麦若葉を用いてもよい。また、いずれの品種の大麦若葉を用いてもよい。大麦若葉は、大麦の若葉が含まれていればよく、茎等の他の部位が含まれていてもよい。
(Young barley leaves)
Barley (Hordeum vulgare L.) is an annual or biennial herb belonging to the family Poaceae, said to be native to Central Asia, and is broadly classified into two-row barley, six-row barley, etc., depending on the panicle shape. The young barley leaves used as the plant material of the present invention are not particularly limited as long as they are normally available, and any young barley leaves, such as two-row barley or six-row barley leaves, may be used. Any variety of young barley leaves may be used. The young barley leaves may include barley leaves, and may also include other parts such as stems.
(甘藷若葉)
甘藷は、ヒルガオ科(Convolvulaceae)に属する植物であり、一般にサツマイモと呼ばれるものである。甘藷の品種は、特に限定されず、例えば、すいおう、ジョイホワイト、コガネセンガン、シロユタカ、サツマスターチ、アヤムラサキなどの品種が挙げられる。
なかでも、ポリフェノール含有量が高いすいおうが好ましい。本発明の植物素材として用いる甘藷若葉は、甘藷の若葉が含まれていればよく、茎等の他の部位が含まれていてもよい。特に、茎葉の先端部分(若茎葉)が好ましく、黄味がかった緑色を保持している状態の若茎葉がさらに好ましい。
(Young sweet potato leaves)
Sweet potato is a plant belonging to the Convolvulaceae family, and is generally called "sweet potato." There are no particular limitations on the variety of sweet potato, and examples of the variety include Suio, Joy White, Koganesengan, Shiroyutaka, Satsuma Sachi, and Ayamurasaki.
Among them, sweet potato leaves with high polyphenol content are preferred. The young sweet potato leaves used as the plant material of the present invention may contain young sweet potato leaves, and may also contain other parts such as stems. In particular, the tip part of the stems and leaves (young stems and leaves) is preferred, and young stems and leaves that retain a yellowish green color are even more preferred.
[本発明の経口組成物]
本発明の経口組成物は、例えば、医薬品(医薬部外品を含む)や、特定保健用食品、栄養機能食品、機能性表示食品等の所定機関より効能の表示が認められた機能性食品などのいわゆる健康食品や、一般的な食品、食品添加剤、飼料等として用いることができる。
[Oral Composition of the Present Invention]
The oral composition of the present invention can be used, for example, as a medicine (including quasi-drugs), a so-called health food such as a functional food whose efficacy has been approved by a designated organization, such as a food for specified health uses, a food with nutrient function claims, or a food with functional claims, or as a general food, a food additive, a feed, or the like.
本発明の経口組成物は、オーラルケア、特に歯周病の予防及び/又は改善に用いることができる。かかるオーラルケア用経口組成物や歯周病予防及び/又は改善用経口組成物は、松樹脂抽出物及び植物素材を含有し、オーラルケアや、歯周病の予防及び/又は改善に用いられる点において、製品として他の製品と区別することができる物であれば特に制限されるものではない。例えば、本発明に係る製品の本体、包装、説明書、宣伝物のいずれかにオーラルケアに効果がある旨や歯周病の予防及び/又は改善効果がある旨を表示したものが本発明の権利範囲に含まれる。 The oral composition of the present invention can be used for oral care, particularly for the prevention and/or improvement of periodontal disease. There are no particular limitations on such oral compositions for oral care or for the prevention and/or improvement of periodontal disease, so long as they contain pine resin extract and plant material and can be distinguished from other products as a product in that they are used for oral care or for the prevention and/or improvement of periodontal disease. For example, the scope of the present invention includes products that display on the main body, packaging, instructions, or advertising materials of the product according to the present invention that they are effective for oral care or that they have the effect of preventing and/or improving periodontal disease.
なお、本発明のオーラルケア用経口組成物や歯周病予防及び/又は改善用経口組成物は、製品の包装等に、本発明における組合せの成分(松樹皮抽出物+副素材)が、オーラルケアや歯周病予防及び/又は改善の有効成分として表示されているものに限られない。例えば、有効成分を特定していないものであってもよい。また、松樹皮抽出物のみを有効成分として表示したものであってもよい。すなわち、本発明のオーラルケア用経口組成物又は歯周病予防及び/又は改善用経口組成物の一形態としては、松樹皮抽出物を有効成分とし、さらに、コーヒーノキ、菩提樹、葛花、大麦若葉及び甘藷若葉から選ばれる少なくとも1つの植物素材を含有する形態を挙げることができる。 The oral composition for oral care and the oral composition for preventing and/or improving periodontal disease of the present invention are not limited to those labeled on the product packaging, etc., with the combined components of the present invention (pine bark extract + auxiliary material) as the active ingredients for oral care and prevention and/or improvement of periodontal disease. For example, the active ingredient may not be specified. Also, the oral composition may be labeled with only pine bark extract as the active ingredient. In other words, one form of the oral composition for oral care and the oral composition for preventing and/or improving periodontal disease of the present invention may be one that contains pine bark extract as an active ingredient and at least one plant material selected from coffee tree, linden tree, kudzu flower, young barley leaves, and young sweet potato leaves.
具体的に、本発明のオーラルケア用経口組成物や歯周病予防及び/又は改善用経口組成物としては、医薬品(医薬部外品を含む)やいわゆる健康食品が挙げられる。いわゆる食品においては、例えば、「歯茎の健康を保つ」「歯茎からの出血を抑える」「歯周ポケットを浅くする」等の歯周病の予防及び/又は改善作用を有する旨を表示したものを例示することができる。 Specific examples of the oral composition for oral care and the oral composition for preventing and/or improving periodontal disease of the present invention include medicines (including quasi-drugs) and so-called health foods. Examples of so-called foods include those that are labeled as having an effect of preventing and/or improving periodontal disease, such as "maintaining healthy gums," "suppressing bleeding from the gums," and "reducing periodontal pocket depth."
本発明の経口組成物の形態としては、例えば、錠状、カプセル状、粉末状、顆粒状、液状、粒状、棒状、板状、ブロック状、固形状、丸状、ペースト状、クリーム状、カプレット状、ゲル状、チュアブル状、スティック状等を挙げることができる。 The oral composition of the present invention may be in the form of, for example, a tablet, capsule, powder, granules, liquid, grain, rod, plate, block, solid, round, paste, cream, caplet, gel, chewable, stick, etc.
本発明の経口組成物は、摂取し易い錠状、カプセル状、粉末状、顆粒状、液状の形態が好ましく、特に口腔内に一定期間滞在する飲料、チュアブル錠、飴、チューインガム等が好ましい。具体的には、口腔内で溶解させるタイプのサプリメントや、ペットボトル、缶、瓶等に充填された容器詰飲料や、水(湯)、牛乳、果汁、青汁等に溶解して飲むためのインスタント飲料や、飴、チューインガム等を例示することができる。これらは食後などに手軽に飲用しやすく、また嗜好性を高めることができるという点で好ましい。 The oral composition of the present invention is preferably in the form of an easy-to-ingest tablet, capsule, powder, granule, or liquid, and is particularly preferably in the form of a beverage, chewable tablet, candy, chewing gum, etc. that remains in the oral cavity for a certain period of time. Specific examples include supplements that dissolve in the oral cavity, packaged beverages filled in PET bottles, cans, jars, etc., instant beverages that are dissolved in water (hot water), milk, fruit juice, green juice, etc., and candy, chewing gum, etc. These are preferred because they are easy to drink after meals and can increase palatability.
本発明の経口組成物における松樹皮抽出物及び植物素材(本発明の成分)の含有量としては、その効果の奏する範囲で適宜含有させればよい。 The content of the pine bark extract and plant material (ingredients of the present invention) in the oral composition of the present invention may be appropriately determined within the range in which the desired effect is achieved.
一般的には、本発明の経口組成物が医薬品やサプリメントの場合には、本発明の成分が乾燥質量換算で全体の0.1~100質量%含まれていることが好ましく、1~85質量%含まれていることがより好ましく、5~70質量%含まれていることがさらに好ましい。 In general, when the oral composition of the present invention is a pharmaceutical or supplement, the components of the present invention are preferably contained in an amount of 0.1 to 100% by mass, more preferably 1 to 85% by mass, and even more preferably 5 to 70% by mass, of the total mass calculated on a dry weight basis.
本発明の効果をより有効に発揮させるためには、本発明の成分が乾燥質量換算で本発明の経口組成物全体の80%以上含まれていることが好ましく、90%以上含まれていることがより好ましく、95%以上含まれていることがさらに好ましく、100%であることが特に好ましい。 In order to more effectively exert the effects of the present invention, the components of the present invention are preferably contained in an amount of 80% or more, more preferably 90% or more, even more preferably 95% or more, and particularly preferably 100% of the total oral composition of the present invention, calculated on a dry mass basis.
本発明の経口組成物における松樹皮抽出物と、植物素材との配合質量比としては、乾燥質量換算で、1:0.001~1:1000の範囲であることが好ましく、1:0.01~1:500の範囲であることがより好ましく、1:0.1~1:200の範囲であることがさらに好ましい。 The mass ratio of the pine bark extract to the plant material in the oral composition of the present invention is preferably in the range of 1:0.001 to 1:1000, more preferably in the range of 1:0.01 to 1:500, and even more preferably in the range of 1:0.1 to 1:200, calculated on a dry mass basis.
本発明の経口組成物の摂取量としては特に制限はないが、本発明の効果をより顕著に発揮させる観点から、成人の1日当たり、松樹皮抽出物摂取量が、0.5mg/日以上となるように摂取することが好ましく、1mg/日以上となるように摂取することがより好ましく、1.5mg/日以上となるように摂取することがさらに好ましい。その上限は、例えば、500mg/日であり、好ましくは400mg/日である。本発明の経口組成物は、オーラルケアを必要とする方であれば特に限定されないが、8割程度が歯周病にかかっているといわれる30~40代の成人や、歯茎の弱った高齢者が摂取することが好ましい。 There is no particular limit to the amount of intake of the oral composition of the present invention, but from the viewpoint of more significantly exerting the effects of the present invention, it is preferable for an adult to take pine bark extract in an amount of 0.5 mg/day or more, more preferably 1 mg/day or more, and even more preferably 1.5 mg/day or more per day. The upper limit is, for example, 500 mg/day, preferably 400 mg/day. The oral composition of the present invention is not particularly limited as long as it is for those who require oral care, but it is preferable for it to be taken by adults in their 30s and 40s, about 80% of whom are said to suffer from periodontal disease, and elderly people with weakened gums.
本発明の経口組成物は、1日の摂取量が前記摂取量となるように、1つの容器に、又は例えば2~3の複数の容器に分けて、1日分として収容することができる。 The oral composition of the present invention can be stored as a daily dose in a single container or divided into multiple containers, for example, 2 to 3, so that the daily intake amount is the above-mentioned amount.
本発明の経口組成物は、必要に応じて、経口用として許容される本発明の成分以外の成分を添加して、公知の方法によって製造することができる。本発明の成分以外の成分としては、例えば、水溶性ビタミン(ビタミンB1、B2、B3、B5、B6、B12、B13、B15、B17、ビオチン、コリン、葉酸、イノシトール、PABA、ビタミンC、ビタミンP)、油溶性ビタミン(ビタミンA、D、E、K)等のビタミン類;カルシウム、マグネシウム、リン、鉄等のミネラル類;タウリン、ニンニク等に含まれる含硫化合物;ヘスペリジン、ケルセチン等のフラバノイド或いはフラボノイド類;コラーゲン等のタンパク質;ペプチド;アミノ酸;動物性油脂;植物性油脂;動物・植物の粉砕物又は抽出物等を挙げることができる。 The oral composition of the present invention can be produced by a known method by adding, as necessary, components other than the components of the present invention that are acceptable for oral use. Examples of components other than the components of the present invention include vitamins such as water-soluble vitamins (vitamins B1, B2, B3, B5, B6, B12, B13, B15, B17, biotin, choline, folic acid, inositol, PABA, vitamin C, vitamin P) and oil-soluble vitamins (vitamins A, D, E, K); minerals such as calcium, magnesium, phosphorus, and iron; sulfur-containing compounds contained in taurine and garlic; flavanoids or flavonoids such as hesperidin and quercetin; proteins such as collagen; peptides; amino acids; animal fats and oils; vegetable fats and oils; crushed products or extracts of animals and plants, etc.
以下、本発明を実施例に基づき説明する。 The present invention will now be described with reference to examples.
[実施例1]
(試験方法)
Porphyromonas gingivalis(以下、P.gingivalis)を、アネロパック・ケンキ(三菱化学株式会社製)および角型ジャー(三菱化学株式会社製)を用いて嫌気環境にし、高圧蒸気滅菌した変法GAMブイヨン(日水製薬株式会社製)で37℃で培養した。
P.gingivalisをダルベッコリン酸緩衝生理食塩水(ナカライテスク株式会社製)で希釈し、濁度が0.5McFarlamdとなるように調製した。濁度の指標には、マクファーランドスタンダード(シスメックス・ビオメリュー株式会社製)を用いた。
[Example 1]
(Test method)
Porphyromonas gingivalis (hereinafter referred to as P. gingivalis) was cultured at 37°C in modified GAM bouillon (manufactured by Nissui Pharmaceutical Co., Ltd.) that had been sterilized by high-pressure steam, in an anaerobic environment created using Anaeropack Kenki (manufactured by Mitsubishi Chemical Corporation) and a square jar (manufactured by Mitsubishi Chemical Corporation).
P. gingivalis was diluted with Dulbecco's phosphate buffered saline (Nacalai Tesque, Inc.) to adjust the turbidity to 0.5 McFarland standard (Sysmex bioMérieux, Inc.) was used as an index of turbidity.
変法GAM寒天培地(日水製薬株式会社製)を高圧蒸気滅菌後、滅菌シャーレに注ぎ、プレート培地を作製した。プレート培地に、上記0.5McFarlandに調製したP.gingivalisを一様に塗布した。 Modified GAM agar medium (manufactured by Nissui Pharmaceutical Co., Ltd.) was sterilized by high-pressure steam and poured into a sterile petri dish to prepare a plate medium. P. gingivalis prepared to the above 0.5 McFarland concentration was evenly applied to the plate medium.
PBSまたはDMSOを用いて被験物質(松樹皮抽出物及び/又は副素材)を所定の濃度となるように調製した。かかる被験物質を、抗生物質検定用6mm濾紙(GEヘルスケア製)に15μL滴下し、上記P.gingivalisを塗布したシャーレに貼り付けた。 The test substance (pine bark extract and/or secondary material) was prepared to a specified concentration using PBS or DMSO. 15 μL of the test substance was dropped onto 6 mm antibiotic test filter paper (GE Healthcare), which was then attached to the petri dish coated with P. gingivalis.
アネロパック・ケンキ、角型ジャーおよび恒温培養機を用いて37℃、嫌気環境で2~3日培養した。 The bacteria were cultured for 2-3 days in an anaerobic environment at 37°C using Anaeropack Kenki, a square jar, and an incubator.
シャーレ内に形成された各被験物質の阻止円の直径を測定し、抗生物質検定用濾紙の直径(6mm)を除算した。各プレートにポジティブコントロールとして設けたイソジンの阻止円の直径から6mmを除算した値で各被験物質の増殖抑制作用を補正した(被験物質阻止円の直径-6mm(mm)/イソジン阻止円の直径-6mm(mm))。各被験物質による増殖抑制作用を、松樹皮抽出物単体(50又は100mg/mL)に対する割合で算出し、各被験物質のP.gingivalisに対する増殖抑制作用を評価した。 The diameter of the inhibition circle formed by each test substance in the petri dish was measured and divided by the diameter (6 mm) of the filter paper for antibiotics testing. The growth inhibitory effect of each test substance was corrected by the value obtained by dividing the diameter of the inhibition circle of Isodine, which was placed on each plate as a positive control, by 6 mm (diameter of inhibition circle of test substance - 6 mm (mm) / diameter of inhibition circle of Isodine - 6 mm (mm)). The growth inhibitory effect of each test substance was calculated as a ratio to that of the pine bark extract alone (50 or 100 mg/mL), and the growth inhibitory effect of each test substance against P. gingivalis was evaluated.
なお、被験物質としては、以下に示す市販品又は調製品を用いた。
[松樹皮抽出物]
フランス海岸松樹皮抽出物である松樹皮抽出物(東洋新薬社;フラバンジェノール(登録商標))を用いた。
The test substances used were the commercially available products or preparations shown below.
[Pine bark extract]
French maritime pine bark extract (Toyo Shinyaku Co., Ltd.; Flavangenol (registered trademark)) was used.
[副素材]
コーヒーノキ(Coffee robusta)は、市販されているコーヒーの種子(生コーヒー豆)のエキス末を用いた。
菩提樹(Tilia cordata Mill.)は、市販されている花のエキス末を用いた。
葛花(Pueraria thomsonii)は、熱水抽出した花のエキス末(東洋新薬社)を用いた。
大麦若葉は、粉砕末(東洋新薬社)を含水エタノールで抽出したエキス末を用いた。
甘藷若葉は、粉砕末(東洋新薬社)を含水エタノールで抽出したエキス末を用いた。
[Secondary material]
For Coffee robusta, commercially available extract powder of coffee seeds (green coffee beans) was used.
For linden tree (Tilia cordata Mill.), a commercially available flower extract powder was used.
For kudzu flowers (Pueraria thomsonii), a powdered extract of the flowers extracted with hot water (Toyo Shinyaku Co., Ltd.) was used.
For the barley leaves, an extract powder was used, which was obtained by extracting crushed barley leaves (Toyo Shinyaku Co., Ltd.) with aqueous ethanol.
For the young sweet potato leaves, an extract powder was used, which was obtained by extracting crushed powder (Toyo Shinyaku Co., Ltd.) with aqueous ethanol.
各被験物質のP.gingivalisに対する増殖抑制作用の評価結果を図1~5に示す。図中のFVGは、松樹皮抽出物(フラバンジェノール(登録商標))を意味する。 The evaluation results of the growth inhibitory effect of each test substance on P. gingivalis are shown in Figures 1 to 5. In the figures, FVG stands for pine bark extract (Flavangenol (registered trademark)).
図1~5に示すように、松樹皮抽出物と特定の植物素材を組み合わせることにより、P.gingivalisの増殖が効果的に抑制されることがわかる。特に、コーヒーノキ、菩提樹、大麦若葉及び甘藷若葉は単独では効果が弱い若しくはないにもかかわらず、松樹皮抽出物と組み合わせることで、P.gingivalisに対する増殖抑制作用が効果的に高まった。葛花はそのものにも増殖抑制作用が見られたが、松樹皮抽出物と組み合わせることでより効果が高まった。よって、本発明の経口組成物は、P.gingivalisの増殖を効果的に抑制することで、歯周病を予防及び/又は改善し、また、歯周病に特有な口臭を予防及び/又は改善する、優れたオーラルケア用経口組成物であることがわかる。 As shown in Figures 1 to 5, it can be seen that the growth of P. gingivalis is effectively inhibited by combining pine bark extract with specific plant materials. In particular, although coffee tree, linden tree, young barley leaves, and young sweet potato leaves have weak or no effect when used alone, when combined with pine bark extract, the growth inhibitory effect against P. gingivalis is effectively enhanced. Kudzu flower itself has a growth inhibitory effect, but this effect is further enhanced when combined with pine bark extract. Therefore, it can be seen that the oral composition of the present invention is an excellent oral composition for oral care that effectively inhibits the growth of P. gingivalis, thereby preventing and/or improving periodontal disease and preventing and/or improving bad breath that is specific to periodontal disease.
[実施例2](錠剤の製造)
松樹皮抽出物 12mg
菩提樹エキス末(花由来) 200mg
ショ糖脂肪酸エステル 350mg
セラック 10mg
香料 2mg
還元麦芽糖 残部
からなる混合物を打錠し、300mgの錠剤4粒を製造した。
[Example 2] (Preparation of tablets)
Pine bark extract 12mg
Linden extract powder (flower derived) 200mg
Sucrose fatty acid ester 350mg
Shellac 10mg
Fragrance 2mg
Reduced maltose remainder
The mixture was compressed into four 300 mg tablets.
[実施例3](チュアブルタブレットの製造)
松樹皮抽出物 1.5mg
コーヒーノキエキス末(生コーヒー豆由来) 150mg
ヒドロキシプロピルセルロース 250mg
ショ糖脂肪酸エステル 50mg
アスパルテーム 30mg
香料 3mg
還元麦芽糖 残部
からなる混合物を打錠し、500mgのチュアブルタブレット2粒を製造した。
[Example 3] (Production of chewable tablets)
Pine bark extract 1.5mg
Coffee extract powder (derived from green coffee beans) 150mg
Hydroxypropyl cellulose 250mg
Sucrose fatty acid ester 50mg
Aspartame 30mg
Fragrance 3mg
Reduced maltose remainder
The mixture was compressed into two 500 mg chewable tablets.
[実施例4](顆粒剤の製造)
松樹皮抽出物 50mg
大麦若葉末 2000mg
フラクトオリゴ糖 200mg
還元麦芽糖 残部
からなる混合物を混合後に造粒し、3gの顆粒剤を製造した。
[Example 4] (Preparation of granules)
Pine bark extract 50mg
Barley leaf powder 2000mg
Fructooligosaccharides 200mg
Reduced maltose remainder
The mixture was mixed and then granulated to produce 3 g of granules.
[実施例5](粉末剤の製造)
松樹皮抽出物 100mg
甘藷若葉末 1500mg
茶抽出物 50mg
デキストリン 残部
からなる混合物を混合し、3gの粉末剤を製造した。
[Example 5] (Preparation of powder)
Pine bark extract 100mg
Sweet potato leaf powder 1500mg
Tea extract 50mg
Dextrin Remainder
The mixture was mixed to prepare 3 g of a powder.
[実施例6](キャンディの製造)
松樹皮抽出物 30mg
コーヒーノキエキス末(生コーヒー豆由来) 50mg
菩提樹エキス末(花由来) 20mg
甘味料(アスパルテーム・L-フェニルアラニン化合物、
アセスルファムK、ステビア) 30mg
香料 10mg
還元麦芽糖水飴 残部
からなる3gのキャンディ1粒を常法に従って製造した。
[Example 6] (Production of candy)
Pine bark extract 30mg
Coffee extract powder (derived from green coffee beans) 50mg
Linden extract powder (flower derived) 20mg
Sweeteners (aspartame, L-phenylalanine compounds,
Acesulfame K, stevia) 30mg
Fragrance 10mg
Reduced maltose syrup Remainder
One candy weighing 3 g was prepared according to a conventional method.
[実施例7](容器詰め飲料の製造)
松樹皮抽出物 200mg
葛花エキス 35mg
紅茶葉エキス末 500mg
アスコルビン酸ナトリウム 50mg
水 残部
からなる350mlの容器詰め飲料を常法に従って製造した。
[Example 7] (Production of bottled beverage)
Pine bark extract 200mg
Kudzu flower extract 35mg
Black tea leaf extract powder 500mg
Sodium ascorbate 50mg
Water Remaining
A 350 ml bottled beverage consisting of the above was produced in a conventional manner.
本発明の経口組成物は、高い歯周病予防及び/又は改善効果を有する健康食品等として用いることができることから、本発明の産業上の有用性は高い。 The oral composition of the present invention can be used as a health food or the like that has a high periodontal disease prevention and/or improvement effect, and therefore the present invention is highly useful industrially.
Claims (1)
An oral composition for oral care comprising a pine bark extract as an active ingredient, the oral composition further comprising linden.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022110040A JP7475718B2 (en) | 2017-01-31 | 2022-07-07 | Oral Care Compositions |
JP2024063182A JP2024074971A (en) | 2017-01-31 | 2024-04-10 | Oral composition for oral care |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017015623A JP6886174B2 (en) | 2017-01-31 | 2017-01-31 | Oral composition for oral care |
JP2021078826A JP7108336B2 (en) | 2017-01-31 | 2021-05-06 | Oral composition for oral care |
JP2022110040A JP7475718B2 (en) | 2017-01-31 | 2022-07-07 | Oral Care Compositions |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021078826A Division JP7108336B2 (en) | 2017-01-31 | 2021-05-06 | Oral composition for oral care |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024063182A Division JP2024074971A (en) | 2017-01-31 | 2024-04-10 | Oral composition for oral care |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022125300A JP2022125300A (en) | 2022-08-26 |
JP7475718B2 true JP7475718B2 (en) | 2024-04-30 |
Family
ID=63109302
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017015623A Active JP6886174B2 (en) | 2017-01-31 | 2017-01-31 | Oral composition for oral care |
JP2021078826A Active JP7108336B2 (en) | 2017-01-31 | 2021-05-06 | Oral composition for oral care |
JP2022110040A Active JP7475718B2 (en) | 2017-01-31 | 2022-07-07 | Oral Care Compositions |
JP2024063182A Pending JP2024074971A (en) | 2017-01-31 | 2024-04-10 | Oral composition for oral care |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017015623A Active JP6886174B2 (en) | 2017-01-31 | 2017-01-31 | Oral composition for oral care |
JP2021078826A Active JP7108336B2 (en) | 2017-01-31 | 2021-05-06 | Oral composition for oral care |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024063182A Pending JP2024074971A (en) | 2017-01-31 | 2024-04-10 | Oral composition for oral care |
Country Status (1)
Country | Link |
---|---|
JP (4) | JP6886174B2 (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001511153A (en) | 1997-02-04 | 2001-08-07 | ブイ. コスバブ,ジョン | Compositions and methods for prevention and treatment of vascular degenerative diseases |
JP2003334032A (en) | 2002-03-12 | 2003-11-25 | Suehito Yamagami | Health supplement food having ameliorating action for somnipathy |
JP2004339113A (en) | 2003-05-14 | 2004-12-02 | Ichimaru Pharcos Co Ltd | Agent for preventing and ameliorating chapped skin by stress |
JP2005179206A (en) | 2003-12-17 | 2005-07-07 | Lion Corp | Oral cavity composition |
WO2005089784A1 (en) | 2004-03-19 | 2005-09-29 | Toyo Shinyaku Co., Ltd. | Composition for oral cavity |
JP2006199661A (en) | 2005-01-24 | 2006-08-03 | Sunstar Inc | Coaggregation inhibitor |
JP2007186457A (en) | 2006-01-13 | 2007-07-26 | Ichimaru Pharcos Co Ltd | Tryptase activity inhibitor and its utilization |
JP2011246434A (en) | 2010-04-28 | 2011-12-08 | Fancl Corp | Blood glucose lowering agent, visceral fat accumulation inhibitor, tg lowering agent and promoter for fecal fat excretion using ethanol extract of tilia cordata flower as effective component |
JP2013023450A (en) | 2011-07-15 | 2013-02-04 | Maruzen Pharmaceut Co Ltd | Dipeptidyl peptidase iv inhibitor |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3614479B2 (en) * | 1993-11-10 | 2005-01-26 | 森下仁丹株式会社 | Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them |
JP2003250493A (en) * | 2001-12-28 | 2003-09-09 | Toyo Shinyaku:Kk | Anticavity food comprising granulated substance of barley young leaf |
JP2003250480A (en) * | 2001-12-28 | 2003-09-09 | Toyo Shinyaku:Kk | Breath odor eliminating food comprising granulated substance of barley young leaf |
JP2005047832A (en) * | 2003-07-30 | 2005-02-24 | Nippon Zettoc Co Ltd | Oral cavity composition |
JP2005237291A (en) * | 2004-02-26 | 2005-09-08 | Toyo Shinyaku:Kk | Health food |
-
2017
- 2017-01-31 JP JP2017015623A patent/JP6886174B2/en active Active
-
2021
- 2021-05-06 JP JP2021078826A patent/JP7108336B2/en active Active
-
2022
- 2022-07-07 JP JP2022110040A patent/JP7475718B2/en active Active
-
2024
- 2024-04-10 JP JP2024063182A patent/JP2024074971A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001511153A (en) | 1997-02-04 | 2001-08-07 | ブイ. コスバブ,ジョン | Compositions and methods for prevention and treatment of vascular degenerative diseases |
JP2003334032A (en) | 2002-03-12 | 2003-11-25 | Suehito Yamagami | Health supplement food having ameliorating action for somnipathy |
JP2004339113A (en) | 2003-05-14 | 2004-12-02 | Ichimaru Pharcos Co Ltd | Agent for preventing and ameliorating chapped skin by stress |
JP2005179206A (en) | 2003-12-17 | 2005-07-07 | Lion Corp | Oral cavity composition |
WO2005089784A1 (en) | 2004-03-19 | 2005-09-29 | Toyo Shinyaku Co., Ltd. | Composition for oral cavity |
JP2006199661A (en) | 2005-01-24 | 2006-08-03 | Sunstar Inc | Coaggregation inhibitor |
JP2007186457A (en) | 2006-01-13 | 2007-07-26 | Ichimaru Pharcos Co Ltd | Tryptase activity inhibitor and its utilization |
JP2011246434A (en) | 2010-04-28 | 2011-12-08 | Fancl Corp | Blood glucose lowering agent, visceral fat accumulation inhibitor, tg lowering agent and promoter for fecal fat excretion using ethanol extract of tilia cordata flower as effective component |
JP2013023450A (en) | 2011-07-15 | 2013-02-04 | Maruzen Pharmaceut Co Ltd | Dipeptidyl peptidase iv inhibitor |
Non-Patent Citations (1)
Title |
---|
口腔衛生会誌,2007年,Vol.57,pp.605-612 |
Also Published As
Publication number | Publication date |
---|---|
JP2024074971A (en) | 2024-05-31 |
JP6886174B2 (en) | 2021-06-16 |
JP2021113230A (en) | 2021-08-05 |
JP2018123078A (en) | 2018-08-09 |
JP7108336B2 (en) | 2022-07-28 |
JP2022125300A (en) | 2022-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4235254B2 (en) | Methioninase inhibitor | |
JP6029546B2 (en) | Beverage | |
JP7507460B2 (en) | Composition for preventing and/or improving menopausal symptoms | |
JP2017112935A (en) | Powder green juice drink | |
KR20180007834A (en) | Composition for cell regeneration comprising extract of ginseng floral axis | |
KR102371417B1 (en) | Composition for anti inflammation comprising extract of ginseng floral axis | |
KR20140005552A (en) | Composition for preventing or treating aging or cancer comprising camellia extract as an active ingredient | |
KR100504351B1 (en) | Food composition for reducing alcoholic hangup containing plant extracts or powders | |
JP7475718B2 (en) | Oral Care Compositions | |
KR101690369B1 (en) | Anti-obesity composition containing bitter melon mixture hot water extract and manufacturing method thereof | |
KR20170053536A (en) | Beverages for preventing respiratory disease and hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
JP2014239699A (en) | Blood adiponectin amount increasing agent | |
JP6757995B2 (en) | Oral composition | |
KR20170059221A (en) | Antioxidant or anti-aging composition comprising the extract of stem and leaf of Rubus coreanus Miquel | |
JP7464960B2 (en) | OPH activity enhancer | |
KR101806220B1 (en) | Antioxidant or anti-aging composition comprising lettuce flower extract or its fraction | |
JP7016510B2 (en) | Blood cholesterol elevation inhibitory composition | |
JP7452874B2 (en) | Oral composition | |
JP7452856B2 (en) | Oral composition | |
JP7271017B2 (en) | Composition for suppressing elevation of blood cholesterol | |
JP2019176828A (en) | Oral composition | |
JP5694056B2 (en) | Methioninase inhibitor | |
KR101852032B1 (en) | Beverages for preventing hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
JP2023089202A (en) | Blood cholesterol rise inhibitory composition | |
KR20230099707A (en) | Composition for preventing or relieving hangovers containing extracts from natural materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220708 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230605 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230622 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230911 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231107 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240205 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240314 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240325 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240410 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7475718 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |